Harnessing an integrated glyco-nanovaccine technology for enhanced cancer immunotherapy

Mayumi Niimura(Kumamoto University), Toshiro Moroishi(Kumamoto University)

Communications Medicine

August 29, 2025

10.1038/s43856-025-01102-3

Cited by 2

Related Papers

Hippo pathway in cancer cells induces NCAM1+αSMA+ fibroblasts to modulate tumor microenvironment

|Communications Biology|2024|11

Peptide Modulation Overrides Glycan Synergy in Gold Nanoparticle‐Based Vaccines for Cancer Immunotherapy

|Cancer Medicine|2025|1

Hippo pathway in cancer cells modulates tumor microenvironment by inducing immunosuppressive NCAM1+αSMA+ fibroblasts

|Research Square|2024|0